Position in TGTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$46,779,404
+$1,973,876 QoQ
Shares Held
1,408,170
-6.3% QoQ
Ownership
0.920%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,425,095,484 across 521 Biotechnology names. TGTX ranks #57 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in TGTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $46,779,404 | 1,408,170 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $44,805,528 | 1,503,037 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $45,076,807 | 1,247,801 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $50,480,037 | 1,402,613 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $80,853,105 | 2,050,548 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $65,149,458 | 2,164,434 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $50,626,903 | 2,164,468 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $26,484,715 | 1,488,742 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $17,822,116 | 1,171,737 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $25,440,367 | 1,489,483 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $15,689,040 | 1,876,680 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $41,984,118 | 1,690,182 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $19,142,546 | 1,272,776 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $9,159,254 | 774,240 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,230,640 | 376,798 | Shares | Defined | 2022-11-14 | |
| 2021-12-31 | $10,758,598 | 566,242 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $22,636,986 | 680,198 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,678,736 | 301,076 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $3,054,047 | 63,362 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $13,208,397 | 253,910 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,749,905 | 140,131 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,160,980 | 162,268 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,084,160 | 313,431 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||